山东药玻
(600529)
| 流通市值：189.20亿 | | | 总市值：189.20亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,343,274,311.11 | 1,466,329,926.87 | 1,106,144,387.57 | 960,691,339.67 |
| 应收票据及应收账款 | 1,719,526,912.21 | 1,646,346,464.57 | 1,630,343,249.69 | 1,614,971,994.43 |
| 其中：应收票据 | 691,905,868.03 | 676,231,103.74 | 651,782,941.4 | 633,213,952.45 |
| 应收账款 | 1,027,621,044.18 | 970,115,360.83 | 978,560,308.29 | 981,758,041.98 |
| 应收款项融资 | 50,229,310.75 | 54,833,544.96 | 113,640,169.3 | 105,104,184.55 |
| 预付款项 | 69,670,848.97 | 68,795,500.36 | 68,132,953.41 | 100,846,452.69 |
| 其他应收款合计 | 2,459,458.76 | 1,780,552.79 | 2,175,436.66 | 2,596,903.65 |
| 存货 | 1,033,270,321.63 | 1,054,610,571.71 | 1,115,819,247.9 | 1,142,431,214.34 |
| 其他流动资产 | 2,627,935.82 | 35,006,155.57 | 2,997,072.76 | 18,622,588.47 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,738,693,082.83 | 5,545,605,960.05 | 5,356,088,463.32 | 5,500,500,045.65 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 50,000 | 50,000 | 50,000 | 50,000 |
| 固定资产 | 2,951,381,463.47 | 2,994,659,152.84 | 2,344,758,102.91 | 2,404,402,268.37 |
| 在建工程 | 542,013,060.72 | 470,144,579.84 | 551,782,328.41 | 468,254,827.43 |
| 无形资产 | 251,997,999.94 | 253,666,243 | 255,334,665.3 | 257,007,232.14 |
| 递延所得税资产 | 38,139,728.78 | 37,802,151.87 | 30,962,885.19 | 32,572,120.72 |
| 其他非流动资产 | 65,796,073.21 | 16,793,463.24 | 479,992,716.14 | 405,966,856.79 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,849,378,326.12 | 3,773,115,590.79 | 3,662,880,697.95 | 3,568,253,305.45 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,588,071,408.95 | 9,318,721,550.84 | 9,018,969,161.27 | 9,068,753,351.1 |
| 流动负债: | | | | |
| 短期借款 | 1,825,579.24 | 1,825,579.24 | 5,224,907.96 | 10,820,497.49 |
| 应付票据及应付账款 | 1,376,928,985.25 | 1,393,701,560.89 | 1,232,520,348.54 | 1,279,580,406 |
| 其中：应付票据 | 688,069,685.8 | 628,105,970.03 | 581,723,383.16 | 649,936,688.53 |
| 应付账款 | 688,859,299.45 | 765,595,590.86 | 650,796,965.38 | 629,643,717.47 |
| 合同负债 | 70,031,435.42 | 61,788,588.12 | 57,622,412.77 | 63,773,227.89 |
| 应付职工薪酬 | 61,194,424.18 | 44,190,102.57 | 18,323,911.34 | 17,097,391.81 |
| 应交税费 | 45,863,975.01 | 34,472,084.02 | 51,741,778.79 | 52,052,810.58 |
| 其他应付款合计 | 143,337,065.05 | 120,676,617.91 | 144,550,759.19 | 335,318,962.85 |
| 应付股利 | - | - | - | 199,084,233.9 |
| 其他流动负债 | 64,331,748.67 | 69,937,705.87 | 80,111,604.72 | 107,155,504.86 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,763,513,212.82 | 1,726,592,238.62 | 1,590,095,723.31 | 1,865,798,801.48 |
| 非流动负债: | | | | |
| 递延收益 | 70,089,448.78 | 57,620,534.05 | 53,781,535.99 | 55,502,954.59 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 70,089,448.78 | 57,620,534.05 | 53,781,535.99 | 55,502,954.59 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,833,602,661.6 | 1,784,212,772.67 | 1,643,877,259.3 | 1,921,301,756.07 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 663,614,113 | 663,614,113 | 663,614,113 | 663,614,113 |
| 资本公积 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 |
| 专项储备 | 70,763,318.29 | 71,592,747.65 | 73,743,761.57 | 74,832,699.22 |
| 盈余公积 | 534,179,562.73 | 534,179,562.73 | 469,422,189.93 | 469,422,189.93 |
| 未分配利润 | 3,798,791,232.04 | 3,578,001,833.5 | 3,481,191,316.18 | 3,252,462,071.59 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,754,468,747.35 | 7,534,508,778.17 | 7,375,091,901.97 | 7,147,451,595.03 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,754,468,747.35 | 7,534,508,778.17 | 7,375,091,901.97 | 7,147,451,595.03 |
| 负债和股东权益合计 | 9,588,071,408.95 | 9,318,721,550.84 | 9,018,969,161.27 | 9,068,753,351.1 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-19 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |